These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine]. D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825 [No Abstract] [Full Text] [Related]
4. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease. Falkmer S; Samuelson G; Sjölin S Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388 [No Abstract] [Full Text] [Related]
5. Introduction. Symposium on copper metabolism and Wilson's disease. Goldstein NP; Owen CA Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351 [No Abstract] [Full Text] [Related]
6. The development of cirrhosis in Wilson's disease. Sternlieb I Clin Gastroenterol; 1975 May; 4(2):367-79. PubMed ID: 1092490 [No Abstract] [Full Text] [Related]
7. Treatment of hepatolenticular degeneration. (Wilson's disease). Spellberg MA Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739 [No Abstract] [Full Text] [Related]
13. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives. Prasad R; Kaur G; Walia BN Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519 [TBL] [Abstract][Full Text] [Related]
14. Prevention of Wilson's disease in asymptomatic patients. Sternlieb I; Scheinberg IH N Engl J Med; 1968 Feb; 278(7):352-9. PubMed ID: 5635646 [No Abstract] [Full Text] [Related]
15. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases]. Lange J Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323 [No Abstract] [Full Text] [Related]
16. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet. Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484 [No Abstract] [Full Text] [Related]
17. Iron accumulation in the liver of male patients with Wilson's disease. Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763 [TBL] [Abstract][Full Text] [Related]
18. Wilson's disease: a 1984 perspective. Ede RJ; Mowat AP Compr Ther; 1984 Dec; 10(12):40-7. PubMed ID: 6518737 [No Abstract] [Full Text] [Related]
19. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper. O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862 [No Abstract] [Full Text] [Related]
20. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine]. Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326 [No Abstract] [Full Text] [Related] [Next] [New Search]